Optimization of sentinel lymph node mapping in bladder cancer using near-infrared fluorescence imaging

Journal of Surgical Oncology

Volumn 110, Issue 7, 2014, Pages 845-850

  Schaafsma, B E ^a   Verbeek, F P R ^a   Elzevier, H W ^a   Tummers, Q R J G ^a   Van Der Vorst, J R ^a   Frangioni, J V ^b   Van De Velde, C J H ^a   Pelger, R C M ^a   Vahrmeijer, A L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Bladder Cancer; Fluorescence Imaging; Image Guided Surgery; Indocyanine Green; Sentinel Lymph Node

Indexed keywords

HUMAN SERUM ALBUMIN INDOCYANINE GREEN; TRACER; UNCLASSIFIED DRUG; COLORING AGENT; FLUORESCENT DYE; INDOCYANINE GREEN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CYSTECTOMY; FEASIBILITY STUDY; FEMALE; FLUORESCENCE IMAGING; HUMAN; LYMPH NODE DISSECTION; LYMPHOSCINTIGRAPHY; MALE; MIDDLE AGED; NEAR INFRARED FLUORESCENCE IMAGING; PATIENT HISTORY OF RADIOTHERAPY; PERITUMORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE MAPPING; SENTINEL LYMPH NODE METASTASIS; TUMOR INVASION; UTERINE CERVIX CANCER; DIAGNOSTIC USE; FOLLOW UP; LYMPH NODE; NEAR INFRARED SPECTROSCOPY; NEOPLASMS; PATHOLOGY; PROCEDURES; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SURGERY; URINARY BLADDER NEOPLASMS;

AGED; COLORING AGENTS; FEASIBILITY STUDIES; FEMALE; FLUORESCENT DYES; FOLLOW-UP STUDIES; HUMANS; INDOCYANINE GREEN; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SPECTROSCOPY, NEAR-INFRARED; URINARY BLADDER NEOPLASMS;

EID: 84922279690     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23740     Document Type: Article

References (35)

1. Sharir S, Fleshner NE:, Lymph node assessment and lymphadenectomy in bladder cancer. J Surg Oncol 2009; 99: 225-231.
2. Hurle R, Naspro R:, Pelvic lymphadenectomy during radical cystectomy: a review of the literature. Surg Oncol 2010; 19: 208-220.
3. Leijte JA, Hughes B, Graafland NM, et al.,: Two-center evaluation of dynamic sentinel node biopsy for squamous cell carcinoma of the penis. J Clin Oncol 2009; 27: 3325-3329.
4. Morton DL, Thompson JF, Essner R, et al.,: Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999; 230.
5. Cox CE, Pendas S, Cox JM, et al.,: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998; 227: 645-651.
6. van der Pas MH, Meijer S, Hoekstra OS, et al.,: Sentinel-lymph-node procedure in colon and rectal cancer: A systematic review and meta-analysis. Lancet Oncol 2011; 12: 540-550.
7. Liedberg F, Chebil G, Davidsson T, et al.,: Intraoperative sentinel node detection improves nodal staging in invasive bladder cancer. J Urol 2006; 175: 84-88.
8. Sherif A, De La Torre M, Malmstrom PU, Thorn M:, Lymphatic mapping and detection of sentinel nodes in patients with bladder cancer. J Urol 2001; 166: 812-815.
9. Sherif A, Garske U, De La Torre M, Thorn M:, Hybrid SPECT-CT: an additional technique for sentinel node detection of patients with invasive bladder cancer. Eur Urol 2006; 50: 83-91.
10. Marits P, Karlsson M, Sherif A, et al.,: Detection of immune responses against urinary bladder cancer in sentinel lymph nodes. Eur Urol 2006; 49: 59-70.
11. Malmstrom PU, Ren ZP, Sherif A, et al.,: Early metastatic progression of bladder carcinoma: Molecular profile of primary tumor and sentinel lymph node. J Urol 2002; 168: 2240-2244.
12. Roth B, Wissmeyer MP, Zehnder P, et al.,: A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol 2010; 57: 205-211.
13. Metildi CA, Kaushal S, Luiken GA, et al.,: Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model. J Surg Oncol 2013.
14. van den Berg NS, van Leeuwen FW, van der Poel HG:, Fluorescence guidance in urologic surgery. Curr Opin Urol 2012; 22: 109-120.
15. Verbeek FP, van der Vorst JR, Schaafsma BE, et al.,: Intraoperative near infrared fluorescence guided identification of the ureters using low dose methylene blue: A first in human experience. J Urol 2013; 190: 574-579.
16. Sakurai T, Endo M, Shimizu K, et al.,: Axillary reverse mapping using fluorescence imaging is useful for identifying the risk group of postoperative lymphedema in breast cancer patients undergoing sentinel node biopsies. J Surg Oncol 2013.
17. Thurber GM, Figueiredo JL, Weissleder R:, Detection limits of intraoperative near infrared imaging for tumor resection. J Surg Oncol 2010.
18. Frangioni JV:, In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 2003; 7: 626-634.
19. Vahrmeijer AL, Hutteman M, van der Vorst JR, et al.,: Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol 2013.
20. Schaafsma BE, Mieog JS, Hutteman M, et al.,: The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol 2011; 104: 323-332.
21. Verbeek FP, van der Vorst JR, Schaafsma BE, et al.,: Image-guided hepatopancreatobiliary surgery using near-infrared fluorescent light. J Hepatobiliary Pancreat Sci 2012; 19: 626-637.
22. Fujisawa Y, Nakamura Y, Kawachi Y, Otsuka F:, Indocyanine green fluorescence-navigated sentinel node biopsy showed higher sensitivity than the radioisotope or blue dye method, which may help to reduce false-negative cases in skin cancer. J Surg Oncol 2012.
23. Knapp DW, Adams LG, Degrand AM, et al.,: Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light. Eur Urol 2007; 52: 1700-1708.
24. Mieog JS, Troyan SL, Hutteman M, et al.,: Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer. Ann Surg Oncol 2011; 18: 2483-2491.
25. Scelsi R, Scelsi L, Gritti A, et al.,: Structure of the lymphatic microcirculation in the human urinary bladder with different intraluminal pressure and distension. Lymphology 1996; 29: 60-66.
26. Ohnishi S, Lomnes SJ, Laurence RG, et al.,: Organic alternatives to quantum dots for intraoperative near-infrared fluorescent sentinel lymph node mapping. Mol Imaging 2005; 4: 172-181.
27. van der Poel HG, Buckle T, Brouwer OR, et al.,: Intraoperative Laparoscopic Fluorescence Guidance to the Sentinel Lymph Node in Prostate Cancer Patients: Clinical Proof of Concept of an Integrated Functional Imaging Approach Using a Multimodal Tracer. Eur Urol 2011; 60: 826-833.
28. Nieweg OE:, False-negative sentinel node biopsy. Ann Surg Oncol 2009; 16: 2089-2091.
29. Gazquez C, Ribal MJ, Marin-Aguilera M, et al.,: Biomarkers vs conventional histological analysis to detect lymph node micrometastases in bladder cancer: A real improvement ? BJU Int 2012; 110: 1310-1316.
30. May M, Herrmann E, Bolenz C, et al.,: Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy. Ann Surg Oncol 2011; 18: 2018-2025.
31. Leissner J, Ghoneim MA, Abol-Enein H, et al.,: Extended radical lymphadenectomy in patients with urothelial bladder cancer: Results of a prospective multicenter study. J Urol 2004; 171: 139-144.
32. Triantafyllou M, Studer UE, Birkhauser FD, et al.,: Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer. Eur J Cancer 2013; 49: 616-624.
33. Lerner SP:, Editorial comment on: Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light. Eur Urol 2007; 52: 1708-1709.
34. Schaafsma BE, Verbeek FP, van der Vorst JR, et al.,: Ex vivo sentinel node mapping in colon cancer combining blue dye staining and fluorescence imaging. J Surg Res 2013; 183: 253-257.
35. Greco F, Cadeddu JA, Gill IS, et al.,: Current Perspectives in the Use of Molecular Imaging To Target Surgical Treatments for Genitourinary Cancers. Eur Urol 2014; 65: 947-964.